Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Professor of Medicine, Division of Infectious Diseases
University of Colorado School of Medicine
Director, University of Colorado HIV/AIDS Clinical Program
Anschutz Medical Campus
Aurora, Colorado

Topics of Professional Interest:
  • Clinical outcomes in HIV care
  • Antiretroviral therapy
  • Clinical research updates
  • Indications and limitations of antiretroviral therapy
  • Opportunistic infection management
Current Professional Summary:

Dr Johnson is Director of the Infectious Disease Group Practice and HIV/AIDS Clinical Program at the University of Colorado Hospital in Aurora, Colorado. He is a Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at the University of Colorado School of Medicine.

Committees and Organizations:
  • Director, Infectious Disease Group Practice, University Hospital
  • Member, Denver Ryan White Planning Council Priorities Committee
  • Medical Director, Mountain-Plains AIDS Education and Training Center
  • Member, HIVQUAL Advisory Committee
  • Fellow, American College of Physicians
  • Fellow, Infectious Diseases Society of America
Honors and Awards:
  • Denver's Top Doctors (Multiple years, 2001-2010)
  • Outstanding Physician of the Year, University of Colorado Hospital (2006)
  • Infectious Disease Fellowship Teaching Award (2000)
  • President's Award for Outstanding Clinical Service, University of Colorado Hospital (1998)
  • Elected to Fellowship, American College of Physicians (1994)
Education:
  • Bethany College, BA (1980)
  • Northwestern University, MD (1984)
  • Fitzsimons Army Medical Center, Residency, Internal Medicine (1984-1987)
  • Walter Reed Army Medical Center, Fellowship, Infectious Diseases (1987-1990)
Selected Publications:
  1. Johnson SC. Syphilis. In: Rakel RE, Bope ET, eds. Conn's Current Therapy. 53rd ed. Philadelphia, PA: W.B. Saunders; 2001:770-772.
  2. Johnson SC, Benson CA, Johnson DW, Weinberg A. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution. Clin Infect Dis. 2001;32:815-819.
  3. Johnson SC, Gerber JG. Advances in HIV/AIDS therapy. Adv Intern Med. 2000;45:1-40.
  4. Williams WJ, Johnson SC. Syphilis. In: Edlich RF, ed. Advances in Medicine. Arlington, VA: ABI Professional Publications; 2000:168-172.
  5. Young B, Johnson S, Bahktiari M, et al. Resistance mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy failure. J Infect Dis. 1998;178:1497-1501.
  6. Akler ME, Johnson DW, Burman WJ, Johnson SC. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis. Ophthalmology. 1998;105:651-657.
  7. Aronson NE, Wortmann GW, Johnson SC, et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis. 1998;27:1457-1464.
  8. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med. 1997;337:307-314.
  9. Magill AJ, Grogl M, Johnson SC, Gasser RA Jr. Visceral infection due to Leishmania tropica in a veteran of Operation Desert Storm who presented 2 years after leaving Saudi Arabia. Clin Infect Dis. 1994;19:805-806.
  10. Teel LD, Finelli MR, Johnson SC.Isolation of Mycoplasma species from bronchoalveolar lavages of patients positive and negative for human immunodeficiency virus. J Clin Microbiol. 1994;32:1387-1389.

Presentations

Improving the Management of HIV Disease®: An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management

An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management